|
|
Article: Digene Files Declaratory Judgment Action Against Enzo Biochem.
- Article from:
- Business Wire
- Article date:
- March 15, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business/Technology Editors & Health/Medical Writers
BOXBOROUGH, Mass.--(BUSINESS WIRE)--March 15, 2002
Cytyc Corporation (Nasdaq:CYTC) was advised today that Digene Corporation has filed a declaratory judgment action against Enzo Biochem, Inc. in the United States District Court for the District of Delaware, seeking a declaratory judgment that Digene's Hybrid Capture(R) products do not infringe any valid claims of Enzo's United States patent no. 6,221,581 B1 (the "`581 Patent"), and that the claims of the `581 Patent are invalid.
On February 19, 2002, Cytyc and Digene announced that they had signed a definitive merger agreement pursuant to ...